Cite Score:
1.77
ELSEVIER SCOPUS

Diagnosis of Men-I Syndrome on 68Ga-DOTANOC PET-CT and Role of Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE

AUTHORS

Santosh kumar Gupta 1 , * , Suhas Singla 1 , Nishikant A Damle 1 , Krishankant Agarwal 1 , Chandersekhar Bal 1

AUTHORS INFORMATION

1 Department of Nuclear Medicine, All India Institute of Medical Sciences, santoshaiims@gmail.com, India

How to Cite: kumar Gupta S, Singla S, A Damle N, Agarwal K, Bal C. Diagnosis of Men-I Syndrome on 68Ga-DOTANOC PET-CT and Role of Peptide Receptor Radionuclide Therapy With 177Lu-DOTATATE, Int J Endocrinol Metab. Online ahead of Print ; 10(4):629-633. doi: 10.5812/ijem.4313.

ARTICLE INFORMATION

International Journal of Endocrinology and Metabolism: 10 (4); 629-633
Published Online: September 29, 2012
Article Type: Case Report
Received: February 1, 2012
Accepted: May 6, 2012
Crossmark

Crossmark

CHEKING

READ FULL TEXT
Abstract

Abstract: MEN-I is a rare genetic disorder classically characterized by a predisposition to tumors of the parathyroid glands, anterior pituitary gland, and pancreatic islet cells. We present a case of MEN-I syndrome diagnosed using predominantly nuclear medicine imaging followed by radionuclide therapy, thus emphasizing the role of nuclear imaging in diagnosing and treating MEN-I.

Keywords

Multiple Endocrine Neoplasia-I Nuclear Imaging

© 2012, International Journal of Endocrinology and Metabolism. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.

Full Text

Full text is available in PDF

COMMENTS

LEAVE A COMMENT HERE: